Related Experiment Video

Updated: Mar 16, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma

Yaobing Chen1, Dong Kuang1, Xia Zhao1,2

  • 1Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Oncotarget
|August 18, 2016
PubMed

Insights

This study identifies miR-497-5p as a tumor suppressor in angiosarcoma by down-regulating KCa3.1. Inhibiting KCa3.1 or increasing miR-497-5p shows potential for angiosarcoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Angiosarcoma is a rare cancer with a poor prognosis.
  • Identifying key molecular players in angiosarcoma development is crucial for targeted therapies.

Purpose of the Study:

  • To identify microRNAs (miRNAs) and their target genes associated with angiosarcoma malignancy.
  • To investigate the functional role of the miR-497-5p/KCa3.1 axis in angiosarcoma progression.

Main Methods:

  • miRNA microarrays and RT-PCR to identify differentially expressed miRNAs.
  • Immunohistochemistry and Western blotting to assess KCa3.1 expression.
  • Luciferase assays to confirm direct targeting.
  • Cell proliferation, cell cycle, and invasion assays.
  • In vivo angiosarcoma xenograft models.

Main Results:

  • miR-497-5p was down-regulated, while its target KCa3.1 was up-regulated in angiosarcoma.
  • miR-497-5p directly targets KCa3.1 mRNA.
  • Inhibition of KCa3.1 or restoration of miR-497-5p suppressed angiosarcoma cell proliferation, cell cycle progression, and invasion.
  • Both KCa3.1 inhibition and miR-497-5p mimicry reduced tumor growth in vivo.

Conclusions:

  • The tumor suppressor miR-497-5p inhibits angiosarcoma malignancy by down-regulating KCa3.1.
  • The miR-497-5p/KCa3.1 pathway represents a potential therapeutic target for angiosarcoma.
Keywords:
cell cyclehemangiomapotassium channelsarcoma

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K